METSERA ANNOUNCES POSITIVE TOPLINE PHASE 2A CLINICAL DATA FOR ITS ULTRA-LONG ACTING GLP-1 RECEPTOR AGONIST, MET-097I

Reuters · 01/07 12:04

Please log in to view news